IP Library › Assignment 055709/0279
Patent Assignment
Reel/Frame 055709/0279

Merger

Recorded: 2021-03-24 Pages: 3
Assignor
NEUROVANCE, INC.
Executed: 2017-11-30
Assignee
OTSUKA AMERICA PHARMACEUTICAL, INC.
2440 RESEARCH BLVD., ROCKVILLE, MARYLAND, 20850
Covered Property (1)
Use of (1R,5S)-(+)-1-(Naphthalen-2-Yl)-3-Azabicyclo[3.1.0]Hexane in the Treatment of Conditions Affected by Monoamine Neurotransmitters
Application: 17/200,719 →
Publication: US 2021/0267940
Related Assignments (8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 24, 2021
From: MCKINNEY, ANTHONY; BYMASTER, FRANK
To: NEUROVANCE, INC.
Reel/Frame 055705/0778 →
Assignment of Assignor's Interest Mar 24, 2021
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 055709/0257 →
Assignment of Assignor's Interest Mar 24, 2021
From: MCKINNEY, ANTHONY ALEXANDER; BYMASTER, FRANK
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 055710/0392 →
Assignment of Assignor's Interest Aug 12, 2021
From: BYMASTER, FRANK; MCKINNEY, ANTHONY ALEXANDER
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 057159/0600 →
Assignment of Assignor's Interest Aug 12, 2021
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 057159/0609 →
Assignment of Assignor's Interest Aug 12, 2021
From: MCKINNEY, ANTHONY; BYMASTER, FRANK
To: NEUROVANCE, INC.
Reel/Frame 057159/0634 →
Assignment of Assignor's Interest Aug 12, 2021
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 057179/0379 →
Merger Aug 12, 2021
From: NEUROVANCE, INC.
To: OTSUKA AMERICA PHARMACEUTICAL, INC.
Reel/Frame 057179/0393 →